Certain proteins and other substances are known as
biomarkers because they signal the presence of cancer and reveal its type. Gynecologic oncologist Dr. Scott Richard explains how doctors test for
biomarkers and
genetic mutations that can signal
ovarian cancer or raise the risk of developing it.
Biomarker testing can reveal different types of
ovarian cancer, and this can lead to more effective treatment choices.
Genetic testing, including the well-known tests for
BRCA1 and
BRCA2, can help you understand your risk, take steps to reduce it, or help family members with the mutations reduce their risk.
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about ovarian cancer which will help other patients, caregivers and families.
-
Share with family and friends: